Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
It combines the effects of GLP-1 agonism with those of GIP, potentially offering additional benefits: - Enhanced insulin secretion and sensitivity - Greater appetite suppression - Improved lipid metabolism - Potential direct effects on adipose tissue[1] This dual action may explain why tirzepatide has shown superior efficacy in clinical trials, demonstrating greater reductions in HbA1c levels and body weight compared to existing therapies, including semaglutide[4]
Bilirubin prohibits oxidative stress injury by directly scavenging reactive oxygen radicals and indirectly by restraining the activity of nitrogen compounds [92, 93]
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
Both are once-weekly injections from Eli Lilly, but retatrutide adds a third hormone receptor (glucagon) on top of the GLP-1 and GIP receptors that tirzepatide already targets
Stay informed.
US$ 25.55
US$ 24.24
US$ 21.29
US$ 21.15
US$ 20.56
US$ 26.79
